Ghost Tree Capital, LLC Rocket Pharmaceuticals, Inc. Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $1.24 Million - $1.77 Million	75,000 New	75,000 $1.49 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $1.59 Million - $3.33 Million	-200,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $2.96 Million - $5.33 Million	-225,000 Reduced 52.94%	200,000 $3.17 Million
Q4 2021 Feb 16, 2022	BUY	$21.52 - $36.02 $1.61 Million - $2.7 Million	75,000 Added 21.43%	425,000 $9.28 Million
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $6.17 Million - $11 Million	225,000 Added 180.0%	350,000 $10.5 Million
Q2 2021 Aug 11, 2021	SELL	$39.41 - $47.25 $7.88 Million - $9.45 Million	-200,000 Reduced 61.54%	125,000 $5.54 Million
Q1 2021 May 14, 2021	SELL	$43.34 - $65.91 $7.58 Million - $11.5 Million	-175,000 Reduced 35.0%	325,000 $14.4 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $2.33 Million - $5.96 Million	100,000 Added 25.0%	500,000 $27.4 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $5.13 Million - $7.15 Million	-250,000 Reduced 38.46%	400,000 $9.14 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $485,500 - $1.26 Million	-50,000 Reduced 7.14%	650,000 $9.07 Million
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $830,250 - $1.82 Million	75,000 Added 12.0%	700,000 $15.9 Million
Q3 2019 Nov 14, 2019	BUY	$10.85 - $14.78 $1.79 Million - $2.44 Million	165,000 Added 35.87%	625,000 $7.28 Million
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.81 $2.1 Million - $2.77 Million	-140,000 Reduced 23.33%	460,000 $6.9 Million
Q4 2018 Feb 14, 2019	BUY	$11.21 - $23.53 $2.24 Million - $4.71 Million	200,000 Added 50.0%	600,000 $8.89 Million
Q3 2018 Nov 14, 2018	BUY	$18.5 - $25.49 $925,000 - $1.27 Million	50,000 Added 14.29%	400,000 $9.85 Million
Q2 2018 Aug 14, 2018	SELL	$14.58 - $23.0 $7.29 Million - $11.5 Million	-500,000 Reduced 58.82%	350,000 $6.87 Million
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $9.93 Million - $16.3 Million	850,000 New	850,000 $15.9 Million

Others Institutions Holding RCKT

# of Institutions

210

Shares Held

93.3M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$182 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$116 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$63.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$57.1 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$46.3 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $780M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account